PD-110843 |
ZONISAMIDE |
CI-912 |
ZONEGRAN |
AD-810 |
ZONISAMIDUM |
ZONISAMIDA |
BENZO[D]ISOXAZOL-3-YL-METHANESULFONAMIDE |
1,2-BENZISOXAZOLE-3-METHANESULFONAMIDE |
ZONEGRAN® |
3-(SULFAMOYLMETHYL)-1,2-BENZISOXAZOLE |
chembl:CHEMBL750 |
rxcui:39998 |
pubchem.compound:5734 |
drugbank:00909 |
chemidplus:68291-97-4 |
Year of Approval | 2000 |
Drug Class | anticonvulsants |
Drug Indications | anticonvulsant |
Drug Indications | antipsychotic agent |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | appetite suppressant |
inhibitor (inhibitory) |
Trial Name | zonisamide,Zonegran, Trerief |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | zonisamide,Zonegran, Trerief |
Novel drug target | Established target |
Trial Name | Empatic |
inhibitor (inhibitory) |
Trial Name | Empatic |
Novel drug target | Established target |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
inhibitor (inhibitory) |
Trial Name | zonisamide,Zonegran, Trerief |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Novel drug target | Established target |
blocker (inhibitory) |
inhibitor (inhibitory) |
Trial Name | zonisamide,Zonegran, Trerief |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Novel drug target | Established target |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Trial Name | Empatic |
blocker (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
Trial Name | Empatic |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
blocker (inhibitory) |
inhibitor (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
Trial Name | Empatic |
blocker (inhibitory) |
inhibitor (inhibitory) |
Trial Name | zonisamide,Zonegran, Trerief |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
Novel drug target | Established target |
blocker (inhibitory) |
inhibitor (inhibitory) |
Trial Name | Empatic |
Novel drug target | Established target |
Trial Name | OREX-003, olanzapine plus zonisamide SR |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Sodium channel alpha subunit blocker |
ZONISAMIDE | Primary Drug Name |
Drug Class | anticonvulsants |
Year of Approval | 2000 |
Drug Indications | appetite suppressant |
Drug Class | Small Molecule |
FDA Approval | approved |
CHEMBL750 | ChEMBL Drug ID |
D09ZIS | TTD Drug ID |